Open access · CC-BY
via OpenAlex
A novel inhibitor of the insulin/IGF signaling pathway protects from age‐onset, neurodegeneration‐linked proteotoxicity
Tayir Elami, Lorna Moll, Filipa Carvalhal Marques, Yuli Volovik, Hadas Reuveni, Ehud Cohen
Aging Cell · 2013 · ▲ 69 citations
Abstract
Aging manipulation is an emerging strategy aimed to postpone the manifestation of late-onset neurodegenerative disorders such as Alzheimer's (AD) and Huntington's diseases (HD) and to slow their progression once emerged. Reducing the activity of the insulin/IGF signaling cascade (IIS), a prominent aging-regulating pathway, protects worms from proteotoxicity of various aggregative proteins, including the AD-associated peptide, Aβ- and the HD-linked peptide, polyQ40. Similarly, IGF1 signaling reduction protects mice from AD-like disease. These discoveries suggest that IIS inhibitors can serve as new drugs for the treatment of neurodegenerative maladies including AD and HD. Here, we report that NT219, a novel IIS inhibitor, mediates a long-lasting, highly efficient inhibition of this signaling cascade by a dual mechanism; it reduces the autophosphorylation of the IGF1 receptor and directs the insulin receptor substrates 1 and 2 (IRS 1/2) for degradation. NT219 treatment promotes stress resistance and protects nematodes from AD- and HD-associated proteotoxicity without affecting lifespan. Our discoveries strengthen the theme that IIS inhibition has a therapeutic potential as a cure for neurodegenerative maladies and point at NT219 as a promising compound for the treatment of these disorders through a selective manipulation of aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.12171
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Elami, T., Moll, L., Marques, F.C., Volovik, Y., Reuveni, H., & Cohen, E. (2013). A novel inhibitor of the insulin/IGF signaling pathway protects from age‐onset, neurodegeneration‐linked proteotoxicity. <em>Aging Cell</em>. https://doi.org/10.1111/acel.12171
Vancouver
Elami T, Moll L, Marques FC, Volovik Y, Reuveni H, Cohen E. A novel inhibitor of the insulin/IGF signaling pathway protects from age‐onset, neurodegeneration‐linked proteotoxicity. Aging Cell. 2013. doi:10.1111/acel.12171.
BibTeX
@article{tayir2013Anovel,
title = {A novel inhibitor of the insulin/IGF signaling pathway protects from age‐onset, neurodegeneration‐linked proteotoxicity},
author = {Tayir Elami and Lorna Moll and Filipa Carvalhal Marques and Yuli Volovik and Hadas Reuveni and Ehud Cohen},
journal = {Aging Cell},
year = {2013},
doi = {10.1111/acel.12171},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell & Bioscience 2023
Open access · CC-BY
Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome
Rambam Maimonides Medical Journal 2012
Open access · CC-BY
Aging, Protein Aggregation, Chaperones and Neurodegenerative Disorders: Mechanisms of Coupling and Therapeutic Opportunities
Frontiers in Cellular Neuroscience 2014
Open access · CC-BY
Proteostasis in striatal cells and selective neurodegeneration in Huntington’s disease
Diabetes & Metabolism Journal 2013
Open access · CC-BY
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
microPublication biology 2026
Open access · OA
TBC-2, a Rab GTPase activating protein, regulates the localization of the HLH-30/TFEB and PQM-1 transcription factors in the <i>C. elegans</i> intestine.
Oxidative Medicine and Cellular Longevity 2017
Open access · CC-BY